Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "AREA[SponsorSearch](Ironwood Pharmaceuticals, Inc.)"
Count: 42
Selected: 0
| NCT ID | Title |
|---|
| NCT03226899 | A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment | ||
| NCT05740007 | Study of IW-3300 for the Treatment of Bladder Pain in Subjects With Interstitial Cystitis/Bladder Pain Syndrome | ||
| NCT05362695 | A Study of Multiple-ascending Doses of IW-3300 in Healthy Subjects | ||
| NCT05188261 | A Study of Single Ascending Doses of IW-3300 in Healthy Volunteers | ||
| NCT03931785 | A Study of MD-7246 to Treat Abdominal Pain in Patients With Diarrhea-predominant Irritable Bowel Syndrome | ||
| NCT03856970 | Study to Evaluate the Effect of IW-3718 on the Pharmacokinetics of Oral Contraceptive, Levothyroxine, Glyburide, and Digoxin in Healthy Adult Volunteers | ||
| NCT03573908 | A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) | ||
| NCT03561883 | Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs) | ||
| NCT03561090 | A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs) | ||
| NCT02837783 | A Study of the Effect of Linaclotide on Abdominal Girth in Participants With Irritable Bowel Syndrome With Constipation (IBS-C) | ||
| NCT02637557 | A Trial of IW-3718 for 8 Weeks in Patients With Symptomatic Gastroesophageal Reflux Disease (GERD) | ||
| NCT02559206 | Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) | ||
| NCT02291679 | Trial of Linaclotide in Patients With Chronic Idiopathic Constipation | ||
| NCT02289846 | Trial of IW-9179 in Patients With Diabetic Gastroparesis (DGP) | ||
| NCT02030925 | Ph2a Study to Evaluate IW-3718 in Patients With Gastroesophageal Reflux Not Completely Responsive to Proton Pump Inhibitors | ||
| NCT01712412 | Phase 2a Study of IW-9179 to Treat Functional Dyspepsia | ||
| NCT01107236 | Study to Evaluate Efficacy and Safety of IW-6118 in Patients Undergoing Third Molar Extraction | ||
| NCT00938717 | Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) | ||
| NCT00730171 | An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation | ||
| NCT00730015 | Trial of Linaclotide in Patients With Chronic Constipation | ||
| NCT00460811 | Randomized, Double-blind, Dose-range-finding, Phase 2 Study of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation (IBS-C) | ||
| NCT00404001 | Study of Oral MD-0727 Administered to Patients With Primary Hypercholesterolemia | ||
| NCT00402337 | Dose-range-finding, Phase 2 Trial of Oral Linaclotide Acetate Administered to Patients With Chronic Constipation | ||
| NCT00306748 | Phase 2 Study of MD-1100 Acetate Administered for 14 Days to Patients Meeting Criteria for Chronic Constipation | ||
| NCT00258193 | Phase 2 Study of MD-1100 Acetate on Gastrointestinal Transit in Patients With C-IBS | ||
| NCT05760313 | A Study to Assess Adverse Events and Change in Disease Activity in Pediatric Participants (Age 6 Months to <2 Years) With Functional Constipation Who Are Treated With Linaclotide | ||
| NCT05652205 | A Study to Assess Adverse Events and Change in Symptoms With Linaclotide Versus Placebo in Pediatric Subjects, Ages 2 to 5 Years, With Functional Constipation | ||
| NCT04166058 | Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-C | ||
| NCT04110145 | Linaclotide Safety and Efficacy in 2 to 5-Year-Old Participants With Functional Constipation | ||
| NCT04026113 | Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC) | ||
| NCT02590432 | An Open-Label, Long-term Study to Assess the Immunogenicity of LINZESS® (Linaclotide) Administered Orally to Adult Participants With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation | ||
| NCT02559817 | A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation | ||
| NCT02559570 | A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC) | ||
| NCT02270983 | Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain | ||
| NCT02144376 | MRI and Microbiota Analysis in Constipation | ||
| NCT01880424 | A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C) | ||
| NCT01805999 | Ispaghula and Colonic Water Content | ||
| NCT01642914 | Safety and Efficacy of Linaclotide in Patients With Chronic Constipation and Prominent Abdominal Bloating | ||
| NCT00948818 | Trial of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation | ||
| NCT00765999 | An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation | ||
| NCT00765882 | Phase III, Randomized, Double-Blind, Placebo-Controlled, Trial of Linaclotide Administered to Patients With Chronic Constipation | ||
| NCT05796388 | A Study of Virtual Reality and Linaclotide for IBS-C |
